Abstract:Liquid biopsy, the technique used to shed light on diseases via liquid samples, has displayed various advantages, including minimal invasiveness, low risk, and ease of multiple sampling for dynamic monitoring, and has drawn extensive attention from multidisciplinary fields in the past decade. With the rapid development of microfluidics, it has been possible to manipulate targets of interest including cells, microorganisms, and exosomes at a single number level, which dramatically promotes the characterization and analysis of disease-related markers, and thus improves the capability of liquid biopsy. However, when lab-ready techniques transfer into hospital-applicable tools, they still face a big challenge in processing raw clinical specimens, which are usually of a large volume and consist of rare targets drowned in complex backgrounds. Efforts toward the sample preparation of clinical specimens (i.e., recovering/concentrating the rare targets among complex backgrounds from large-volume liquids) are required to bridge the gap between the proof-of-concept demonstrations and practical applications. The throughput, sensitivity, and purity (TSP performance criteria) in sample preparation, i.e., the volume speed in processing liquid samples and the efficiencies of recovering rare targets and depleting the backgrounds, are three key factors requiring careful consideration when implementing microfluidic-based liquid biopsy for clinical practices. Platforms based on a single microfluidic module (single-modal microfluidics) can hardly fulfill all the aforementioned TSP performance criteria in clinical practices, which puts forward an urgent need to combine/couple multiple microfluidic modules into one working system (i.e., multi-modal microfluidics, M3) to realize practically applicable techniques for the sample preparation of liquid biopsy. This perspective briefly summarizes the typical microfluidic-based liquid biopsy techniques and discusses potential strategies to develop M3 systems for clinical practices of liquid biopsy from the aspect of sample preparation.

Microfluidic sampling system for tissue analytics

Hydrogel-Coated Microneedle Arrays for Minimally-Invasive Sampling and Sensing of Specific Circulating Nucleic Acids from Skin Interstitial Fluid.

Microfluidic chip to interface porous microneedles for ISF collection

In-situ Sampling of Lipids in Tissues Using a Porous Membrane Microprobe for Direct Mass Spectrometry Analysis.

Microfluidic Probe for In-Situ Extraction of Adherent Cancer Cells to Detect Heterogeneity Difference by Electrospray Ionization Mass Spectrometry

Coupling Microdroplet-Based Sample Preparation, Multiplexed Isobaric Labeling, and Nanoflow Peptide Fractionation for Deep Proteome Profiling of the Tissue Microenvironment

Digital Microfluidics with Integrated Raman Sensor for High-Sensitivity In-Situ Bioanalysis

Point-of-Care Tissue Analysis Using Miniature Mass Spectrometer

An integrated micro-extracting system facilitates lesion-free biomacromolecules enrichment and detection

(Invited) liquid Biopsy Tool: Integrated Aiot Digital Bead-Based Sensor for Molecular-Fingerprint Profiling of Extracellular Vesicles

A microneedle patch for breast cancer screening via minimally invasive interstitial fluid sampling

Drug screening of cancer cell lines and human primary tumors using droplet microfluidics

Microfluidic chip connected to porous microneedle array for continuous ISF sampling

Automated, high-resolution sampling from ex vivo adipose tissue using droplet-based microfluidics with multiplexed sensing of glycerol and fatty acid secretion

An Integrated Microfluidic System for Multi-Target Biochemical Analysis of a Single Drop of Blood.

Multi-Modal Microfluidics (M3) for Sample Preparation of Liquid Biopsy: Bridging the Gap between Proof-of-Concept Demonstrations and Practical Applications

Sensor-Integrated Microfluidic Approaches for Liquid Biopsies Applications in Early Detection of Cancer

The Use of Microfluidic Technology for Cancer Applications and Liquid Biopsy

Enhanced Interstitial Fluid Extraction and Rapid Analysis via Vacuum Tube-Integrated Microneedle Array Device

Microfluidics-assisted multiplexed biomarker detection for in situ mapping of immune cells in tumor sections

PDMS porous microneedles used as engineered tool in advanced microfluidic devices and their proof-of-concept for biomarker detection